Soaring Oil Prices Threaten Higher European Air Fares Industry Body Warns Biggest bottleneck in the AI buildup fuels DRAM ETF to record Anthropic to Brief Global Financial Regulators on AI Cyber Vulnerabilities Exposed by Mythos Federal Reserve Sees Diminishing Case for Rate Cuts as Jobs Report Highlights Inflation Pressures UK Exports to US Plunge 25 as Trumps Liberation Day Tariffs Reshape Trade Balance Micron CEO Sanjay Mehrotra Reaches Billionaire Status Amid Memory Chip Sector Surge Amgen Releases Q1 2026 Earnings Highlights Waymo Expands Robotaxi Fleet with Ojai Vehicles Targets Lower Expansion Costs QatarEnergy and ExxonMobil Sign Deal to Pipe Cypriot Gas to Europe via Egypt Jamie Dimon Signals Potential Challenges for JPMorgan Bankers Amid Economic Uncertainty OSRH Q4 2025 Earnings EPS Miss of 569 Triggers Stock Decline Immunovant IMVT Q1 2026 Earnings NarrowerThanExpected Loss but EPS Miss Highlights RD Spending PDPA Q4 2025 Earnings Preferred Stock Misses Estimates Slightly Shares Edge Higher Pathward Financial Inc CASH Q1 2026 Earnings EPS Misses Estimates by 254 Stock Holds Steady JBSS Q1 2026 Earnings EPS Surprises to the Upside Beating Estimates by Over 21 PROK Q1 2026 Earnings Narrow Loss Beat Highlights Steady Progress in Cell Therapy Pipeline Cantaloupe Inc CTLP Holds Steady at 1120 as Traders Eye Key Support and Resistance Levels Legend Biotech LEGN Surges Nearly 5 as Biotech Sector Momentum Builds Massimo Group MAMO Tests Key Support at 095 After Marginal Decline BayFirst Financial Corp BAFN Shows Resilience with 224 Gain Testing Key Resistance Microsoft MSFT Slips 08 Key Support Levels in Focus Workday Shares Surge 5 on Improved Margin Outlook Amid AIDriven Growth Data Centres Become New Frontier in Global Computing Power Arms Race Ebola Outbreak Escalates in DRC Clinic Attack Raises Regional Health Security Concerns Ukraines AIEnabled Martian Drones Disrupt Russian Supply Lines Raising Defense Sector Implications Analyst Boosts Venture Global VG Price Target by 2 Citi Initiates Coverage on Alnylam Pharmaceuticals with Buy Rating GURE Q3 2023 Earnings Net Loss of 017 per Share Stock Declines 209 Indivior INDV Holds Steady with Slight Gain as Stock Tests Resistance Near 40